Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Psychology, University of Alberta, Edmonton, AB, Canada.
Curr Neurol Neurosci Rep. 2020 May 5;20(5):13. doi: 10.1007/s11910-020-01029-3.
Therapeutic hypothermia (TH) in stroke demonstrates robust neuroprotection in animals but clinical applications remain controversial. We assessed current literature on the efficacy of TH in ischemic stroke.
We conducted a meta-analysis comparing TH versus controls in studies published until June 2019. Controlled studies reporting on ≥ 10 adults with acute ischemic stroke were included. Primary outcome was functional independence (modified Rankin Scale [mRS] ≤ 2). Twelve studies (n = 351 TH, n = 427 controls) were included. Functional independence did not differ between groups (RR 1.17, 95% CI 0.93-1.46, random-effects p = 0.2). Five studies reported individual mRS outcomes and demonstrated a shift toward better outcome with TH (unadjusted cOR 1.57, 95% CI 1.01-2.44, p = 0.05). Overall complications were higher with TH (RR 1.18, 95% CI 1.06-1.32, p < 0.01). We did not observe an overall beneficial effect of TH in this analysis although some studies showed a shift toward better outcome. TH was associated with increased complications.
动物实验表明,治疗性低温(therapeutic hypothermia,TH)对脑卒中具有显著的神经保护作用,但临床应用仍存在争议。本研究旨在评估目前关于缺血性脑卒中应用 TH 的疗效的文献。
我们对截至 2019 年 6 月发表的研究进行了 TH 与对照组的荟萃分析。纳入了报告≥10 例急性缺血性脑卒中成人患者的对照研究。主要结局为功能独立性(改良 Rankin 量表评分≤2)。共纳入 12 项研究(n=351 例 TH,n=427 例对照组)。两组间功能独立性无差异(RR 1.17,95%CI 0.93-1.46,随机效应 p=0.2)。5 项研究报告了个体改良 Rankin 量表评分结局,表明 TH 治疗后结局更好(未校正比值比 1.57,95%CI 1.01-2.44,p=0.05)。TH 组总体并发症更高(RR 1.18,95%CI 1.06-1.32,p<0.01)。虽然部分研究显示结局有改善趋势,但本分析未观察到 TH 的总体获益效应。TH 与并发症增加相关。